PQL3 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of PRL-3 Antibody

PRL-3 (PTP4A3) is a dual-specificity phosphatase overexpressed in colon, breast, lung, and blood cancers . Antibodies targeting PRL-3 are investigational tools designed to inhibit its oncogenic activity. These antibodies disrupt PRL-3’s interactions with signaling proteins like CNNM3 and block phosphorylation pathways that drive metastasis .

2.1. PRL-3 Antibody Development

  • Nanobody Innovation: Alpaca-derived nanobodies (single-domain antibodies) targeting PRL-3 were developed by the University of Kentucky. These nanobodies bind the PRL-3 active site, reducing interactions with CNNM3 and inhibiting cancer growth in vitro .

  • Specificity: PRL-3 nanobodies show no cross-reactivity with related phosphatases (PRL-1, PRL-2) .

2.2. Functional Impact

EffectMechanismSource
Reduced cell migrationInhibition of IL-1α secretion via NF-κB/Jak2
Tumor growth suppressionBlockade of PRL-3/CNNM3 interaction
Phosphatase inhibitionDirect binding to PRL-3 catalytic domain

2.3. Preclinical Data

  • In vitro: PRL-3 nanobodies reduced cancer cell migration by 40–60% in colon and breast cancer models .

  • In vivo: Antibody-treated mice showed 50% smaller tumors compared to controls .

Technical Advancements

  • Antibody Engineering: Sequences of PRL-3 nanobodies were optimized for stability (Tm = 72°C) and affinity (KD = 2.1 nM) .

  • Screening: High-throughput platforms identified dominant plasma cell lineages producing anti-PRL-3 antibodies with somatic hypermutation rates ≤5% .

Clinical Relevance

PRL-3 antibodies are candidates for:

  1. Diagnostics: Detecting PRL-3 in tumor biopsies .

  2. Therapeutics: Delivering conjugated drugs or radioisotopes to PRL-3+ cancers .

  3. Research Tools: Mapping PRL-3’s interactome via immunoprecipitation .

Challenges and Future Directions

  • Specificity: PRL-3’s structural similarity to PRL-1/2 complicates selective targeting .

  • Delivery: Improving nanobody penetration into solid tumors remains a hurdle .

  • Combination Therapies: Pairing PRL-3 antibodies with checkpoint inhibitors is under exploration .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PQL3 antibody; At2g01918 antibody; F23I14 antibody; T23K3 antibody; PsbQ-like protein 3 antibody; chloroplastic antibody
Target Names
PQL3
Uniprot No.

Target Background

Function
The PQL3 antibody is essential for both the formation and activity of the chloroplast NAD(P)H dehydrogenase (NDH) complex.
Gene References Into Functions
  1. Studies have shown that the absence of PQL3 leads to impaired activity and accumulation of the NDH complex. PMID: 20430763
Database Links

KEGG: ath:AT2G01918

STRING: 3702.AT2G01918.1

UniGene: At.63225

Protein Families
PsbQ family
Subcellular Location
Plastid, chloroplast thylakoid membrane; Peripheral membrane protein; Lumenal side.

Q&A

What is PQL3 antibody and what biological function does its target serve?

PQL3 antibody is a polyclonal antibody raised in rabbits against the Arabidopsis thaliana PQL3 protein . The PQL3 protein (UniProt: Q2V4B2) is essential for both the formation and activity of the chloroplast NAD(P)H dehydrogenase (NDH) complex in plants. This complex plays a crucial role in cyclic electron flow around photosystem I and chlororespiration. The antibody is designed for research applications to detect and study the PQL3 protein in experimental settings, particularly in plant biology research focusing on photosynthetic processes.

What are the technical specifications of commercially available PQL3 antibodies?

Commercial PQL3 antibodies are typically provided as purified polyclonal antibodies raised in rabbits against recombinant Arabidopsis thaliana PQL3 protein . These antibodies are supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . They undergo antigen affinity purification to ensure specificity and are designed exclusively for research applications, not for diagnostic or therapeutic purposes . The antibodies are primarily validated for ELISA and Western blot applications, with specificity for Arabidopsis thaliana as the target species .

What are the recommended storage and handling conditions for PQL3 antibody?

PQL3 antibodies should be stored at -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and performance . Similar to other research antibodies, aliquoting the stock solution into smaller volumes before freezing is recommended to minimize freeze-thaw cycles. When handling the antibody, researchers should follow standard laboratory practices for protein solutions, including using clean pipette tips and sterile containers to prevent contamination. Before each use, the antibody should be gently mixed (not vortexed) to ensure homogeneity without damaging the protein structure.

What applications has PQL3 antibody been validated for?

The PQL3 antibody has been specifically validated for ELISA and Western blot (WB) applications for the identification of the target antigen . When designing experiments, researchers should be aware that using antibodies in non-validated applications may require extensive optimization and validation. Proper validation is critical as research has shown that approximately half of published studies contain potentially incorrect immunohistochemical staining results due to inadequate antibody validation . For novel applications beyond ELISA and WB, researchers should conduct preliminary validation experiments following standards similar to those outlined by Johns Hopkins researchers to ensure reliability .

What controls should be included when using PQL3 antibody in experiments?

When designing experiments with PQL3 antibody, multiple controls are essential to ensure result validity:

  • Positive control: Include samples known to express PQL3 (such as wild-type Arabidopsis thaliana leaf tissue)

  • Negative control: Use samples lacking PQL3 expression (such as PQL3 knockout mutants when available)

  • Primary antibody omission control: Process samples without the primary antibody to detect non-specific binding of secondary antibodies

  • Isotype control: Use non-specific IgG from the same species at equivalent concentration

  • Absorption control: Pre-incubate antibody with excess target antigen to confirm specificity

These controls help address the widespread inconsistencies in antibody use documented by researchers at Johns Hopkins, who found that at least half of reviewed manuscripts contained potentially incorrect results due to inadequate validation practices .

How can I optimize Western blotting protocols when using PQL3 antibody?

For optimal Western blot results with PQL3 antibody:

Sample Preparation:

  • Use fresh plant tissue extracted in buffer containing protease inhibitors

  • Maintain cold temperatures during extraction to prevent protein degradation

  • Consider membrane-enriched fractions for chloroplast proteins

Blocking and Antibody Incubation:

  • Test different blocking agents (BSA vs. non-fat milk) to determine optimal signal-to-noise ratio

  • Optimize primary antibody dilution (starting with manufacturer's recommendation)

  • Include 0.05-0.1% Tween-20 in washing buffers to reduce background

Detection and Analysis:

  • Use enhanced chemiluminescence or fluorescent detection systems for quantitative analysis

  • Include loading controls appropriate for plant samples (e.g., RuBisCO, actin)

  • Document exposure times and imaging parameters for reproducibility

Research on antibody validation emphasizes that optimization is critical, as variations in technique can significantly impact experimental reliability and reproducibility .

How should PQL3 antibody be validated before use in critical experiments?

Before using PQL3 antibody in critical experiments, researchers should perform comprehensive validation:

  • Specificity testing: Perform Western blot analysis using wild-type and PQL3-deficient samples to confirm band specificity at the expected molecular weight

  • Cross-reactivity assessment: Test the antibody against related plant species if cross-species reactivity is claimed

  • Lot-to-lot variation testing: Compare performance between different lots when available

  • Concentration optimization: Determine optimal working dilutions for each application

  • Signal verification: Confirm that signal intensity correlates with known expression patterns of PQL3 in different tissues or experimental conditions

This multi-step validation approach addresses the concerns raised by Johns Hopkins researchers who found widespread inconsistencies in antibody use, often stemming from poor validation practices . Proper validation ensures experimental reliability and reproducibility.

What are the potential cross-reactivity concerns with PQL3 antibody?

When working with PQL3 antibody, researchers should be aware of potential cross-reactivity with:

  • Related PQL family proteins: PQL1 and PQL2 share sequence homology with PQL3 and may cross-react

  • Other NDH complex subunits: Proteins that associate with PQL3 in the NDH complex could be recognized if they share epitopes

  • Species variation: While the antibody is specified for Arabidopsis thaliana, it may recognize orthologs in closely related plant species with varying affinity

To address cross-reactivity concerns, researchers should consider:

  • Performing immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody

  • Using genetic knockout controls where available to confirm specificity

  • Conducting epitope mapping to identify the specific regions recognized by the antibody

Research has shown that antibody validation is frequently overlooked, with Johns Hopkins researchers estimating that at least half of published studies contain potentially incorrect results due to inadequate validation practices .

How can PQL3 antibody be used to study chloroplast NDH complex formation and function?

The PQL3 antibody can be leveraged for advanced studies of the chloroplast NAD(P)H dehydrogenase (NDH) complex through multiple approaches:

Co-immunoprecipitation (Co-IP):

  • Use PQL3 antibody to pull down the protein and associated complex members

  • Identify interaction partners through mass spectrometry analysis

  • Compare complex composition under different physiological conditions

Blue Native PAGE:

  • Apply PQL3 antibody for Western blot analysis after blue native PAGE

  • Investigate intact NDH complex assembly and sub-complexes

  • Compare wild-type plants with photosynthetic mutants

Quantitative Analysis:

  • Measure PQL3 abundance across developmental stages or stress responses

  • Correlate PQL3 levels with NDH activity measurements

  • Study post-translational modifications affecting complex assembly

These approaches can provide insights into how PQL3 contributes to NDH complex formation and function, which is essential for understanding cyclic electron flow and photoprotection mechanisms in plants.

What methodologies can be used to study PQL3 localization within chloroplasts?

To investigate the precise localization of PQL3 within chloroplast structures:

Immunogold Electron Microscopy:

  • Use PQL3 antibody with gold-conjugated secondary antibodies

  • Visualize PQL3 distribution across thylakoid membranes at nanometer resolution

  • Quantify distances between PQL3 and other chloroplast structures

Chloroplast Fractionation:

  • Separate stromal, thylakoid, and envelope fractions

  • Apply PQL3 antibody in Western blot analysis of each fraction

  • Determine the membrane association pattern of PQL3

Confocal Microscopy with Immunofluorescence:

  • Use fixed plant tissue sections with PQL3 antibody

  • Combine with markers for different chloroplast compartments

  • Visualize co-localization patterns within intact tissue context

Each method provides complementary information, and combining approaches offers the most comprehensive understanding of PQL3 localization. Careful validation is essential as the Johns Hopkins study emphasized that antibody-based localization studies are particularly prone to artifacts without proper controls .

What are common troubleshooting approaches for weak or absent signal when using PQL3 antibody?

When encountering weak or absent signal with PQL3 antibody, consider these methodical troubleshooting steps:

Sample Preparation Issues:

  • Ensure proper protein extraction from plant tissue (chloroplast proteins may require specialized extraction buffers)

  • Verify protein integrity through Ponceau S staining

  • Check transfer efficiency for Western blots using reversible stains

Antibody-Related Factors:

  • Test increased antibody concentration (within reasonable range)

  • Extend primary antibody incubation time or temperature

  • Verify antibody viability with positive control samples

  • Consider lot-to-lot variation issues documented in antibody research

Detection System Optimization:

  • Enhance signal using more sensitive detection reagents

  • Increase exposure time within linear range

  • Try alternative secondary antibodies with higher sensitivity

Protein Expression Verification:

  • Confirm PQL3 expression in your experimental system through RT-PCR

  • Consider tissue-specific or condition-dependent expression patterns

  • Verify if post-translational modifications might affect epitope recognition

A systematic approach to troubleshooting is essential, as research shows that technical variations in antibody-based methods significantly impact experimental outcomes .

How can I differentiate between specific and non-specific signals when using PQL3 antibody?

Distinguishing between specific and non-specific signals requires multiple validation approaches:

Experimental Controls:

  • Compare signals between wild-type and PQL3-deficient samples (genetic knockouts or knockdowns)

  • Pre-absorb antibody with purified antigen to deplete specific binding capacity

  • Use secondary antibody-only controls to identify background staining

Signal Characteristics Analysis:

  • Assess molecular weight precision in Western blots (PQL3-specific band versus non-specific bands)

  • Evaluate signal localization pattern against known PQL3 distribution

  • Compare signal intensity across different antibody concentrations (specific signals typically show dose-dependent changes)

Confirmation with Alternative Methods:

  • Verify findings using a second antibody targeting a different epitope of PQL3

  • Correlate antibody-based results with orthogonal methods (e.g., transcript analysis, fluorescent protein tagging)

  • Consider mass spectrometry verification of immunoprecipitated proteins

This multi-faceted approach addresses concerns raised in the Johns Hopkins study, which found that non-specific signals are frequently misinterpreted as positive results in antibody-based research .

How should quantitative data from PQL3 antibody experiments be normalized and analyzed?

For robust quantitative analysis of PQL3 antibody experiments:

Normalization Strategies:

  • For Western blots: Normalize to validated housekeeping proteins appropriate for plant tissues and experimental conditions

  • For ELISA: Include standard curves using recombinant PQL3 protein

  • Account for background signal using negative controls

Statistical Analysis Framework:

  • Perform at least three biological replicates for statistical significance

  • Apply appropriate statistical tests based on data distribution

  • Report variability measures (standard deviation or standard error)

Quantification Methods:

  • Use densitometry software with defined parameters for Western blot analysis

  • Document all image acquisition settings for reproducibility

  • Ensure quantification occurs within linear range of detection

Representative Data Presentation:

  • Include both representative images and quantitative graphs

  • Show both positive and negative controls alongside experimental samples

  • Present full blots including molecular weight markers

Adhering to these rigorous quantification practices addresses the concerns raised by researchers regarding reproducibility in antibody-based experiments .

What are the implications of PQL3 expression changes in plant stress response studies?

When interpreting PQL3 expression changes in stress response studies:

Physiological Context:

  • Correlate PQL3 level changes with photosynthetic parameters (NDH activity, cyclic electron flow rates)

  • Consider the role of the NDH complex in photoprotection during various stresses

  • Evaluate how PQL3 changes might affect energy balance in chloroplasts

Experimental Design Considerations:

  • Include time-course analyses to distinguish between early and late stress responses

  • Compare multiple stress conditions to identify stress-specific versus general responses

  • Control for circadian or developmental regulation that might confound stress responses

Functional Significance Assessment:

  • Determine whether changes in PQL3 levels correlate with changes in NDH complex assembly

  • Evaluate phenotypic consequences in plants with altered PQL3 expression

  • Consider potential post-translational modifications affecting PQL3 function independent of expression level

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.